Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors

Reproductive BioMedicine Online

Volumn 24, Issue 5, 2012, Pages 532-539

  Polyzos, Nikolaos P ^a   Stoop, Dominic ^a   Blockeel, Christophe ^a   Adriaensen, Paul ^a   Platteau, Peter ^a   Anckaert, Ellen ^a   Smitz, Johan ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

AMH; anti M llerian hormone; GnRH antagonist; oocyte donation; oocyte donors; ovarian response

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; FOLLITROPIN; GANIRELIX; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE DONATION; OOCYTE RETRIEVAL; OVARY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT (HEALTH CARE); OVARY; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; TISSUE DONORS;

EID: 84861096340     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.01.024     Document Type: Article

References (26)

1. Anonymous Financial compensation of oocyte donors Fertil. Steril. 88 2007 305 309
2. S.E. Barton, S.A. Missmer, R.K. Ashby, and E.S. Ginsburg Multivariate analysis of the association between oocyte donor characteristics, including basal follicle stimulating hormone (FSH) and age, and IVF cycle outcomes Fertil. Steril. 94 2010 1292 1295
3. N.A. Bersinger, D. Wunder, M.H. Birkhäuser, and J. Guibourdenche Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid Clin. Chim. Acta 384 2007 174 175
4. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil. Steril. 91 2009 705 714
5. S.L. Broer, M. Dolleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum. Reprod. Update 17 2011 46 54
6. Centers for Disease Control and Prevention, 2008. 2008 Assisted Reproductive Technology Report (accessed 01.08.11).
7. L. Dessolle, D.J. Biau, V. de Larouziere, C. Ravel, J.M. Antoine, E. Darai, and J. Mandelbaum Learning curve of vitrification assessed by cumulative summation test for learning curve (LC-CUSUM) Fertil. Steril. 92 2009 943 945
8. A.P. Ferraretti, A. La Marca, B.C. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum. Reprod. 26 2011 1616 1624
9. T. Freour, S. Mirallie, K. Bach-Ngohou, M. Denis, P. Barriere, and D. Masson Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART) Clin. Chim. Acta 375 2007 162 164
10. A. Galindo, D. Bodri, J.J. Guillen, M. Colodron, V. Vernaeve, and O. Coll Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial Gynecol. Endocrinol. 25 2009 60 66
11. C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt Relevance of anti-Mullerian hormone measurement in a routine IVF program Hum. Reprod. 23 2008 1359 1365
12. M.J. Gorrill, L.K. Johnson, P.E. Patton, and K.A. Burry Oocyte donor screening: the selection process and cost analysis Fertil. Steril. 75 2001 400 404
13. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. Te Velde, and F.J. Broekmans Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J. Clin. Endocrinol. Metab. 91 2006 4057 4063
14. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum. Reprod. Update 12 2006 651 671
15. J.R. Lee, S.H. Kim, S.M. Kim, B.C. Jee, S.Y. Ku, C.S. Suh, Y.M. Choi, J.G. Kim, and S.Y. Moon Follicular fluid anti-Mullerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles Fertil. Steril. 89 2008 860 867
16. M. Melo, C.E. Busso, J. Bellver, P. Alama, N. Garrido, M. Meseguer, A. Pellicer, and J. Remohi GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study Reprod. Biomed. Online 19 2009 486 492
17. M.A. Melo, N. Garrido, C. Alvarez, J. Bellver, M. Meseguer, A. Pellicer, and J. Remohi Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program Fertil. Steril. 91 2009 148 156
18. G.S. Nakhuda, N.C. Douglas, M.H. Thornton, M.M. Guarnaccia, R. Lobo, and M.V. Sauer Anti-Mullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors Reprod. Biomed. Online 20 2010 42 47
19. S.M. Nelson, and A. La Marca The journey from the old to the new AMH assay: how to avoid getting lost in the values Reprod. Biomed. Online 23 2011 411 420
20. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy Hum. Reprod. 22 2007 2414 2421
21. A. O'Dowd Fertility regulator seeks views on donation compensation BMJ 341 2010 c4688
22. R. Riggs, T. Kimble, S. Oehninger, S. Bocca, Y. Zhao, B. Leader, and L. Stadtmauer Anti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation Fertil. Steril. 95 2011 410 412
23. D. Stoop, N. De Munck, E. Jansen, P. Platteau, E. Van den Abbeel, G. Verheyen, and P. Devroey Clinical validation of a closed vitrification system in an oocyte-donation programme Reprod. Biomed. Online 2011 10.1016/j.rbmo.2011. 10.015
24. S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, C. Gervy, and Y. Englert Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women Hum. Reprod. 22 2007 1837 1840
25. J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, B.C. Fauser, and F.J. Broekmans Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts Hum. Reprod. 25 2010 221 227
26. M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, B.C.J.M. Fauser, and F.J. Broekmans Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF Hum. Reprod. 22 2007 1919 1924